Table S3.
Parameters | Base case value | Low value | High value | Justification of tested values |
---|---|---|---|---|
Discounting (%) | 4 | 0 | 6 | HAS recommendations |
Safety (reported probability of event) | ||||
Afatinib – diarrhea grade 3 | 0.099 | 0.071 | 0.130 | 95% CI |
Afatinib – diarrhea grade 4 | 0.005 | 0.001 | 0.014 | 95% CI |
Afatinib – rash/acne | 0.059 | 0.038 | 0.084 | 95% CI |
Afatinib – stomatitis grade 3 | 0.041 | 0.024 | 0.063 | 95% CI |
Afatinib – fatigue grade 3 | 0.015 | 0.005 | 0.029 | 95% CI |
Afatinib – nausea grade 3 | 0.010 | 0.003 | 0.022 | 95% CI |
Erlotinib – diarrhea grade 3 | 0.023 | 0.011 | 0.040 | 95% CI |
Erlotinib – diarrhea grade 4 | 0.003 | 0.0001 | 0.010 | 95% CI |
Erlotinib – rash/acne | 0.104 | 0.076 | 0.136 | 95% CI |
Erlotinib – fatigue grade 3 | 0.018 | 0.007 | 0.033 | 95% CI |
Erlotinib – nausea grade 3 | 0.008 | 0.002 | 0.019 | 95% CI |
Utilities and disutilities | ||||
Progression-free survival utility | 0.65 | 0.63 | 0.75 | Low value: low value of 95% CI of two data sources (LUX-Lung 8 trial3 and Nafees et al4) High value: high value of 95% CI of LUX-Lung 8 trial3 data source |
Post-progression survival utility | 0.58 | 0.47 | 0.61 | Low value: Nafees et al4 High value: high value of 95% CI of LUX-Lung 8 trial3 data source |
Diarrhea grade 3 disutility | 0.050 | 0.019 | 0.096 | 95% CI |
Diarrhea grade 4 disutility | 0.050 | 0.019 | 0.096 | 95% CI |
Rash/acne disutility | 0.030 | 0.004 | 0.080 | 95% CI |
Stomatitis grade 3 disutility | 0.131 | 0.112 | 0.151 | 95% CI |
Fatigue grade 3 disutility | 0.070 | 0.036 | 0.114 | 95% CI |
Nausea grade 3 disutility | 0.050 | 0.019 | 0.096 | 95% CI |
Costs (EUR) | ||||
Mean transportation cost per round-trip | 77.06 | 64.76 | 89.41 | Low value: estimated VSL cost High value: estimated taxi cost |
Unit cost for diarrhea grade 3 | 2,801.76 | 1,813.15 | 4,002.05 | 95% CI |
Unit cost for diarrhea grade 4 | 2,801.76 | 1,813.15 | 4,002.05 | 95% CI |
Unit cost for rash/acne | 225.67 | 146.04 | 322.35 | 95% CI |
Unit cost for stomatitis grade 3 | 569.44 | 303.80 | 670.56 | 95% CI |
Unit cost for fatigue grade 3 | 570.57 | 369.24 | 815.01 | 95% CI |
Unit cost for nausea grade 3 | 1,997.00 | 1,292.35 | 2,852.52 | 95% CI |
Monthly monitoring costs in pre-progression and post-progression for all arms | 253.63 | 202.90 | 304.36 | ±20% |
Abbreviations: CI, confidence interval; DSA, deterministic sensitivity analysis; HAS, Haute Autorité de Santé [French National Authority for Health]; VSL, véhicule sanitaire léger [ambulance transport].